Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bell, S. J.
Right arrow Articles by Forse, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, S. J.
Right arrow Articles by Forse, R. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Dietary Fats
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical Trial

Dietary Fish Oil and Cytokine and Eicosanoid Production During Human Immunodeficiency Virus Infection

Stacey J. Bell, DSc, RD

Surgical Metabolism Laboratory, Harvard Medical School, Boston, Massachusetts, Deaconess Hospital, Boston, Harvard Medical School, Boston, Massachusetts

Sambasiva Chavali, PHD

Surgical Metabolism Laboratory, Harvard Medical School, Boston, Massachusetts, Deaconess Hospital, Boston, Harvard Medical School, Boston, Massachusetts

Bruce R. Bistrian, MD, PHD

Deaconess Hospital, Boston, Harvard Medical School, Boston, Massachusetts, Nutrition and Infection Laboratory, Harvard Medical School, Boston, Massachusetts

Christine Apour Connolly, RD

Surgical Metabolism Laboratory, Harvard Medical School, Boston, Massachusetts, Division of General Surgery, Harvard Medical School, Boston, Massachusetts

Tohru Utsunomiya, MD

Surgical Metabolism Laboratory, Harvard Medical School, Boston, Massachusetts, Division of General Surgery, Harvard Medical School, Boston, Massachusetts

R. Armour Forse, MD, PHD

Surgical Metabolism Laboratory, Harvard Medical School, Boston, Massachusetts, Deaconess Hospital, Boston, Harvard Medical School, Boston, Massachusetts

Background : Dietary fish oil (FO) has been shown to modulate the immune system. The purpose of this study was to explore the effects of FO supplementation on the production of dienoic eicosanoids and cytokines in patients with human immunodeficiency virus (HIV) infection. Methods: This was a randomized, prospective, double-blind study that included homosexual males with HIV infection. Patients were asked to consume voluntarily five food bars daily containing FO (n = 10) or safflower oil (SO) (n = 9) for 6 weeks. At baseline and week 6, plasma was obtained to measure incorporation of {omega}-3 fatty acids. At baseline, week 3, and week 6, measurements were made of changes in dienoic eicosanoids and cytokines from lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells (PBMC) or spontaneously releasing cells. Results: In the FO group but not the SO group, there was increased incorporation of the {omega}-3 fatty acid docosahexaenoic acid (DHA) into the phospholipids of the fatty acids of the plasma. In the FO group, there was a significant decrease (p = .01) in 6-keto prostaglandin (PG) F 1{alpha} released from PBMC. There was a significant increase (p = .01) in interleukin (IL)-6 released from the PBMC in the FO group between baseline and week 3 and between week 3 and week 6. At week 6, there was significantly more IL-6 (p = .01) released from the PBMC in the FO group compared with the SO group. There was no change in CD4 cell counts by analysis of variance. Conclusions: The FO-containing food bars were well tolerated and allowed incorporation of {omega}-3 fatty acids to occur. Despite evidence of significant metabolic effects on eicosanoid and cytokine production, widespread clinical use of FO for HIV-infected patients is not warranted without further study, particularly given the trend toward a decline in CD4 cell numbers at this dose and with this type of fish oil. (Journal of Parenteral and Enteral Nutrition 20:43-49, 1996)

Journal of Parenteral and Enteral Nutrition, Vol. 20, No. 1, 43-49 (1996)
DOI: 10.1177/014860719602000143


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
B. R. Bistrian
Dietary Treatment in Secondary Wasting and Cachexia
J. Nutr., January 1, 1999; 129(1): 290S - 290S.
[Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
S. Klein, J. Kinney, K. Jeejeebhoy, D. Alpers, M. Hellerstein, M. Murray, and P. Twomey
Nutrition Support in Clinical Practice: Review of Published Data and Recommendations for Future Research Directions: Summary of a Conference Sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition
JPEN J Parenter Enteral Nutr, May 1, 1997; 21(3): 133 - 156.
[Abstract] [PDF]